CPP
MDT icon

Crow Point Partners’s Medtronic MDT Stock Holding History

Crow Point Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,351
Closed -$297K – 268
2017
Q2 		$297K Buy
+3,351
New +$283K 0.05% 110
2015
Q3 		$36K Buy
545
+115
+27% +$8.47K 0.01% 229
2015
Q2 		$32K Buy
430
+300
+231% +$22.9K ﹤0.01% 236
2015
Q1 		$10K Buy
+130
New +$9.85K ﹤0.01% 233
2014
Q3 		$10K Sell
160
-1,150
-88% -$73.1K ﹤0.01% 231
2014
Q2 		$81K Hold
1,310
– – 0.01% 191
2014
Q1 		$81K Buy
+1,310
New +$76.3K 0.01% 191

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Crow Point Partners's MDT Position: Q3 2017 in Review

Crow Point Partners sold out of Medtronic (MDT) in Q3 2017, closing a stake of 3,351 shares — an estimated $297K sold.

Crow Point Partners first reported a position in MDT in Q1 2014 and held it in 7 quarters. The position peaked at $297K in Q2 2017. 1,291 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • Crow Point Partners reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
  • Crow Point Partners sold 3,351 Medtronic shares in Q3 2017, an estimated $297K.
  • Crow Point Partners first reported a position in Medtronic in Q1 2014 and held it in 7 quarters.
  • Crow Point Partners's Medtronic position peaked at $297K in Q2 2017.
  • 1,291 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Crow Point Partners's 13F filing for Q3 2017, filed 5 Oct 2017.